GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma

NCT06455410 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: GP
DRUG: Adebrelimab
DRUG: concurrent chemoradiotherapy (CCRT)

Sponsor

Sun Yat-sen University